thioflavopiridol CDK inhibitors (Bristol-Myers Squibb)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namethioflavopiridol CDK inhibitors (Bristol-Myers Squibb)
Drug Alias NameBMS-207977BMS-204572
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 1 inhibitorsCell cycle inhibitorsAnticancer protein kinase inhibitors
TargetsCyclin-dependent kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDupont Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDupont PharmaBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A